CHARLES SCHWAB INVESTMENT MANAGEMENT INC - RAPT THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 84 filers reported holding RAPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.

Links
Filings
External links
Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,686,133
-0.4%
221,789
+12.1%
0.00%0.0%
Q2 2023$3,699,702
+3.4%
197,845
+1.5%
0.00%0.0%
Q1 2023$3,577,626
+5.6%
194,966
+13.9%
0.00%0.0%
Q4 2022$3,389,503
-15.4%
171,187
+2.8%
0.00%0.0%
Q3 2022$4,006,000
+44.0%
166,487
+9.2%
0.00%0.0%
Q2 2022$2,782,000
-13.3%
152,418
+4.5%
0.00%0.0%
Q1 2022$3,207,000
-38.6%
145,818
+2.6%
0.00%
-50.0%
Q4 2021$5,219,000
+19.9%
142,073
+1.4%
0.00%
+100.0%
Q3 2021$4,352,000
+69.5%
140,134
+73.5%
0.00%0.0%
Q2 2021$2,568,000
+75.2%
80,760
+22.4%
0.00%0.0%
Q1 2021$1,466,000
+11.8%
66,003
-0.5%
0.00%0.0%
Q4 2020$1,311,000
-37.7%
66,345
+1.4%
0.00%0.0%
Q3 2020$2,106,000
+40.2%
65,397
+26.4%
0.00%0.0%
Q2 2020$1,502,000
+138.0%
51,756
+74.7%
0.00%–
Q1 2020$631,000
+40.8%
29,632
+82.9%
0.00%–
Q4 2019$448,000–16,197–0.00%–
 Download
Other shareholders
RAPT THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$49,189,39517.79%
Euclidean Capital LLC 432,900$7,943,7156.97%
GREAT POINT PARTNERS LLC 1,355,151$24,867,0214.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 875,984$16,074,3063.02%
Trustees of Columbia University in the City of New York 80,580$1,478,6432.64%
Perceptive Advisors 2,291,608$42,051,0071.24%
Cormorant Asset Management, LP 650,000$11,9280.79%
Alphabet Inc. 540,270$9,913,9550.55%
Redmile Group, LLC 688,132$12,627,2220.55%
Orbimed Advisors 1,251,070$22,957,1350.45%
View complete list of RAPT THERAPEUTICS INC shareholders